EPISODE · May 1, 2026 · 14 MIN
Theranos 2018 : She Raised $9 Billion on a Machine That Never Worked — EP21 T1
from Financial Forensics: Autopsy Files · host Sergio Stieben
Elizabeth Holmes raised $900 million from investors including the Walton family, Rupert Murdoch, and former Secretary of State George Shultz. Theranos was valued at $9 billion. The technology — a blood testing device that could run hundreds of tests from a single drop — never worked. The company ran patient tests on commercial machines from Siemens and Abbott, hid the results, and kept raising capital on a demonstration that was theater, not science.🔴 Every corporate failure leaves behind a pattern. FFL Risk Pattern Scan provides access to a searchable library of documented corporate collapses, frauds and restructurings that can be filtered by geography, sector, collapse mechanism and fraud vector. Compare live opportunities against historical cases using pattern matching and risk assessment tools designed for investors, lenders and deal teams. All analysis runs locally and remains private.https://risk-pattern-scan.lovable.app/ This episode dissects the Theranos governance failure, the board composition versus board function gap, and the institutional due diligence collapse that allowed a medical device company to raise nearly a billion dollars without a single independent technical verification. Elizabeth Holmes. Theranos. Silicon Valley fraud. Medical device fraud. Governance failure. Healthcare startup. John Carreyrou. Financial Forensics Labs — Every collapse has a pattern. We dissect it. Layer by layer.Elizabeth Holmes told investors, patients, and regulators that Theranos had built a device that could run two hundred and forty blood tests from a single drop. The device didn't work. It never worked. For twelve years, the company ran real patient tests on third-party machines while telling everyone the results came from its own technology. The board included two former secretaries of state and a former secretary of defense. None of them had scientific or medical expertise. None of them had access to the data that would have shown the technology didn't work. This is the financial autopsy of Theranos: the governance theater mechanism that kept nine and a half billion dollars of valuation alive on a product that failed every independent clinical test it was ever subjected to.
What this episode covers
Elizabeth Holmes raised $900 million from investors including the Walton family, Rupert Murdoch, and former Secretary of State George Shultz. Theranos was valued at $9 billion. The technology — a blood testing device that could run hundreds of tests from a single drop — never worked. The company ran patient tests on commercial machines from Siemens and Abbott, hid the results, and kept raising capital on a demonstration that was theater, not science.🔴 Every corporate failure leaves behind a pattern. FFL Risk Pattern Scan provides access to a searchable library of documented corporate collapses, frauds and restructurings that can be filtered by geography, sector, collapse mechanism and fraud vector. Compare live opportunities against historical cases using pattern matching and risk assessment tools designed for investors, lenders and deal teams. All analysis runs locally and remains private.https://risk-pattern-scan.lovable.app/ This episode dissects the Theranos governance failure, the board composition versus board function gap, and the institutional due diligence collapse that allowed a medical device company to raise nearly a billion dollars without a single independent technical verification. Elizabeth Holmes. Theranos. Silicon Valley fraud. Medical device fraud. Governance failure. Healthcare startup. John Carreyrou. Financial Forensics Labs — Every collapse has a pattern. We dissect it. Layer by layer.Elizabeth Holmes told investors, patients, and regulators that Theranos had built a device that could run two hundred and forty blood tests from a single drop. The device didn't work. It never worked. For twelve years, the company ran real patient tests on third-party machines while telling everyone the results came from its own technology. The board included two former secretaries of state and a former secretary of defense. None of them had scientific or medical expertise. None of them had access to the data that would have shown the technology didn't work. This is the financial autopsy of Theranos: the governance theater mechanism that kept nine and a half billion dollars of valuation alive on a product that failed every independent clinical test it was ever subjected to.
NOW PLAYING
Theranos 2018 : She Raised $9 Billion on a Machine That Never Worked — EP21 T1
No transcript for this episode yet
Similar Episodes
Apr 6, 2026 ·25m
Mar 30, 2026 ·27m